Active	Status	Sponsor type	Region	Phase	Filter
6 Active 0 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

6 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
POULET, Claire
ORBITAL, NCT04233021: Study of Osimertinib in Patients With a Lung Cancer With Brain or Leptomeningeal Metastases With EGFR Mutation	Active, not recruiting	2	57	Europe	Osimertinib	Intergroupe Francophone de Cancerologie Thoracique	Non Small Cell Lung Cancer Metastatic, Leptomeningeal Metastasis, Brain Metastases, EGFR Activating Mutation	03/23	02/24
ADAPTABLE, NCT05781308: Combination of Paclitaxel-bevacizumab ± Atezolizumab in Patients With Advanced NSCLC Progressing After Immunotherapy & Chemotherapy	Recruiting	2	156	Europe	Paclitaxel, Bevacizumab, Avastin, Atezolizumab, Tecentriq	Intergroupe Francophone de Cancerologie Thoracique	Non Small Cell Lung Cancer	09/25	06/26
Ibe2i-TIPCI, NCT05813418: Identification of Predictive Biomarkers for Immune-Related Adverse Events (irAEs) in Patients Undergoing Immune CheckPoint Inhibitors (ICPI) Treatment	Recruiting	N/A	150	Europe	blood retriewal	Centre Hospitalier Universitaire, Amiens, Central Hospital Saint Quentin	Immunotherapy, Immune Checkpoint Inhibitors, Immune-related Adverse Event, Predictive Biomarkers	07/23	07/24
MUCOSIM, NCT04010253: Impact of Bronchial Drainage Technique by the Medical Device Simeox® on Respiratory Function and Symptoms in Adult Patients With Cystic Fibrosis	Recruiting	N/A	42	Europe	SIMEOX, Autogenic drainage	Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche	Cystic Fibrosis	12/23	12/23
HomeCareSIMEOX, NCT04096664: Home Airway Clearance in CF Patients	Recruiting	N/A	160	Europe	SIMEOX	Physio-Assist, Icadom	Pulmonary Cystic Fibrosis	12/24	06/25
PACT-01, NCT04823377: Impact of a Process Optimizing the Decision to Continue or Stop Cancer Treatments in Patients With Advanced Non-small Cell Lung Cancer.	Recruiting	N/A	364	Europe	Usual care, Optimization of the medical decision	Institut Curie	Carcinoma, Non-Small-Cell Lung, Advanced Cancer	09/25	09/26